Ouro Medicines
Company

Ouro Medicines

Biotechnology Research San Francisco, California, United States 16 employees
Employees
16
Contacts
4
Emails
4
Phones
3

Ouro Medicines Overview

Headquarters
San Francisco, California, United States
Industry
Biotechnology Research
Employees
16
Founded
2024
Funding
120.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Ouro Medicines

Ouro Medicines is dedicated to developing immune reset therapeutics for people living with chronic immune-mediated diseases. Our approach is focused on leveraging T cell engagers in B cell mediated diseases to achieve immune resets that enable durable remissions without ongoing immunosuppression for patients. Based in San Francisco, Ouro was founded by Monograph Capital in partnership with GSK. We are also backed by leading investors TPG, NEA, Norwest and more.

Ouro Medicines Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Ouro Medicines Org Chart

Sample employees and titles
Name Title Contact
John Davis Pharma/biotech Executive & Strategic
Email Phone
Kyu Hee Hong Director of Bioanalytical Assays
Email Phone
David Chau Head of Technical Operations
Email Phone
Christina Carlson General Counsel and Chief
Email

Employees by Management Level

Executive 1 profile
VP / Head 1 profile
Director 1 profile
Individual contributor 1 profile

Compare Similar Companies to Ouro Medicines